Are you in pain? Are you sure? On a scale from 0 to 10, where 0 is no pain at all and 10 is the worst pain imaginable, how ...

SAN DIEGO -- The oral full-spectrum microbiome drug EBX-102-02 was well tolerated with mostly mild gastrointestinal adverse ...

The prevalence of irritable bowel syndrome and chronic idiopathic constipation rose significantly during the COVID-19 pandemic.

Self-help cognitive behavioral therapy for irritable bowel syndrome was successfully delivered via mobile application.

Application represents milestone toward broadening patient access to inFoods IBS - inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, ...

EnteroBiotix Presents Positive IBS-C Data at Digestive Disease Week® 2025 <li /> EBX-102-02 was well tolerated and d ...

Medically reviewed by Qin Rao, MD Colon cancer is a type of cancer (abnormal cells growing uncontrollably) that begins in the ...